Ads
related to: Renal Cell Carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
ASCO Meeting News Research News and Press Releases
Newswise· 3 days agoNewswise - ASCO Meeting News: ASCO Meeting News Page 1
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL) By GuruFocus
Investing.com· 2 days agoFollowing this transaction, the insider now owns 5,445 shares of Exelixis Inc. Exelixis Inc is a...
Get Ready for ASCO 2024 Annual Meeting | Newswise
Newswise· 4 days agoASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings a
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Zacks via Yahoo Finance· 4 days agoDr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 3 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla
Zacks via Yahoo Finance· 5 days agoExelixis (EXEL) resolves two patent litigations and grants Cipla a license to market generic...
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 3 days agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment.
Tumor mutations may not predict response to immuno | Newswise
Newswise· 4 days agoMay 22, 2024 – The number of mutations in the DNA of cancerous tumors may not be an indicator of how...
Ads
related to: Renal Cell Carcinoma